Skip to content

AnaptysBio, Inc. ANAB Other Income (Expense)

Other Income (Expense) at other companies

Eli Lilly logo
Eli LillyLLY
-$65M+72.8%
Amgen logo
AmgenAMGN
$75M-95.1%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$188.3M-39.9%
Biogen logo
BiogenBIIB
-$1.1M-144%
Gilead Sciences logo
Gilead SciencesGILD
$235M+172%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$5.7M+55.5%

Segments

By segment

See full
Biopharma Company-$1K
Royalty Management Company$0

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s other income (expense)?
AnaptysBio, Inc. (ANAB) reported other income (expense) of -$18.21M in Q1 2026.
How has AnaptysBio, Inc.'s other income (expense) changed year-over-year?
AnaptysBio, Inc.'s other income (expense) decreased by 55.0% year-over-year, from -$11.75M to -$18.21M.
What is the long-term trend for AnaptysBio, Inc.'s other income (expense)?
Over 3 years (2021 to 2025), AnaptysBio, Inc.'s other income (expense) has grown at a 296.0% compound annual growth rate (CAGR), from -$982K to -$60.96M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.